Severity of COPD at initial spirometry-confirmed diagnosis: Data from medical charts and administrative claims

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 573-581

  Mapel, Douglas W ^a   Dalal, Anand A ^b   Blanchette, Christopher M ^c,d   Petersen, Hans ^c   Ferguson, Gary T ^e  

^a LOVELACE CLINIC FOUNDATION   (United States)

^b GLAXOSMITHKLINE   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e Pulmonary Research Institute of Southeast Michigan   (United States)

Author keywords

Detection; Early treatment; Global initiative for chronic obstructive lung disease (GOLD); Lung function

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; SPIROMETRY; UNITED STATES; EMERGENCY HEALTH SERVICE; HEALTH MAINTENANCE ORGANIZATION; HOSPITAL PATIENT; HOSPITALIZATION; LUNG; MIDDLE AGED; OUTPATIENT; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREDICTIVE VALUE; TIME; VITAL CAPACITY;

ADULT; AGED; COMORBIDITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INPATIENTS; LUNG; MALE; MIDDLE AGED; NEW MEXICO; OUTPATIENTS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME FACTORS; VITAL CAPACITY;

EID: 84859221510     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S16975     Document Type: Article

References (24)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2010). Available from: http://www.gold-copd.org/uploads/users/fles/GOLDReport_April112011.pdf. Accessed October 19, 2011.
2. Radin A, Cote C. Primary care of the patient with chronic obstructive pulmonary disease: part 1, frontline prevention and early diagnosis. Am J Med. 2008;121(7 Suppl):S3-S12.
3. Celli BR. Chronic obstructive pulmonary disease: from unjustified nihilism to evidence-based optimism. Proc Am Thorac Soc. 2006;3(1): 58-65.
4. Celli BR. Update on the management of COPD. Chest. 2008;133(6): 1451-1462.
5. Cooper CB, Dransfeld M. Primary care of the patient with chronic obstructive pulmonary disease: part 4, understanding the clinical manifestations of a progressive disease. Am J Med. 2008;121(7 Suppl): S33-S45.
6. Godtfredsen NS, Lam TH, Hansel TT, et al. COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J. 2008;32(4):844-853.
7. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and futicasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775-789.
8. Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C. Effect of futicasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations. Respir Med. 2008;102(8): 1099-1108.
9. Anzueto A, Ferguson GT, Feldman G, et al. Effect of futicasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes. COPD. 2009;6(5):320-329.
10. Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecifed subgroup analysis of a randomised controlled trial. Lancet. 2009;374(9696):1171-1178.
11. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332-338.
12. Jenkins CR, Jones P W, Calverley PM, et al. Effcacy of salmeterol/ futicasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res. 2009;10:59.
13. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721-732.
14. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB; for US Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2008;148(7): 535-543.
15. Yawn BP, Mapel DW, Mannino DM, et al. Development of the Lung Function Questionnaire (LFQ) to identify airfow obstruction. Int J Chron Obstruct Pulmon Dis. 2010;5:1-10.
16. Hanania NA, Mannino DM, Yawn B P, et al. Validation of the Lung Function Questionnaire: a screener to identify risk of airfow obstruction to aid in early identifcation of COPD. Respir Med. 2011. In press.
17. Calverly PM, Nordyke RJ, Halbert RJ, Isonaka S, Nonikov D. Development of a population-based screening questionnaire for COPD. COPD. 2005;2(2):225-232.
18. Martinez RJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS). COPD. 2008;5(2):85-95.
19. Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ; for COPD Questionnaire Study Group. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006;129(6): 1531-1539.
20. Van Schayck CP, Loozen JM, Wagena E, Akkermans R P, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in a general practice: cross sectional case fnding study. BMJ. 2002;324(7350):1370.
21. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006; 73(3):285-295.
22. Kida K, Wakabayashi R, Mizuuchi T, Murata A. Screening for suspected chronic obstructive pulmonary disease with an eleven-item pre-interview questionnaire (11-Q). Intern Med. 2006;45(21):1201-1207.
23. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523-532.
24. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4(7): 502-506.